Human mycobiome and diseases

doi:10.7518/hxkq.2019.03.017

Abstract

Abstract:

The proportion of mycobiome is less than 1% of human microbiome. However, fungal community plays a key role in human health and diseases. With high-throughput sequencing applications, the structure and composition of mycobiome in the mouth, lung, gut, vagina, and skin have been analyzed, and the role of microbiome in diseases has been investigated. Mycobiome also influences the composition of bacteriome and includes key species that maintain the structure and function of microbial communities. Fungi also influence host immune responses. In this review, we summarized the mycobiome composition at various sites and different diseases and the interactions between fungi-bacteria and fungi-host.

Key words: mycobiome, diseases, bacteriome, interaction, hostimmune response

CLC Number:

Xin Shen,Yufei Yao,Jiyao Li,Yan Li. Human mycobiome and diseases[J]. West China Journal of Stomatology, 2019, 37(3): 314-319.

References 44

[1]	NIH HMP Working Group, Peterson J, Garges S , et al. The NIH human microbiome project[J]. Genome Res, 2009,19(12):2317-2323. doi: 10.1101/gr.096651.109 URL pmid: 19819907
[2]	Arumugam M, Raes J, Pelletier E , et al. Enterotypes of the human gut microbiome[J]. Nature, 2011,473(7346):174-180. doi: 10.1038/nature09944
[3]	Bożena DK, Iwona D, Ilona K . The mycobiome—a friendly cross-talk between fungal colonizers and their host[J]. Ann Parasitol, 2016,62(3):175-184.
[4]	Kumamoto CA . The fungal mycobiota: small numbers, large impacts[J]. Cell Host Microbe, 2016,19(6):750-751. doi: 10.1016/j.chom.2016.05.018 URL
[5]	Sam QH, Chang MW, Chai MW . The fungal mycobiome and its interaction with gut bacteria in the host[J]. Int J Mol Sci, 2017, 18(8). pii: E330. doi: 10.3390/ijms18020330 URL pmid: 5343866
[6]	Ghannoum MA, Jurevic RJ, Mukherjee PK , et al. Characterization of the oral fungal microbiome in healthy individuals[J]. PLoS Pathog, 2010,6(1):e1000713. doi: 10.1371/journal.ppat.1000713 URL
[7]	Dupuy AK, David MS, Li L , et al. Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of malassezia as a prominent commensal[J]. PLoS One, 2014,9(3):e90899. doi: 10.1371/journal.pone.0090899 URL
[8]	Imabayashi Y, Moriyama M, Takeshita T , et al. Molecular analysis of fungal populations in patients with oral candidiasis using next-generation sequencing[J]. Sci Rep, 2016,6:28110.
[9]	Persoon IF, Buijs MJ, Özok AR , et al. The mycobiome of root canal infections is correlated to the bacteriome[J]. Clin Oral Investig, 2017,21(5):1871-1881. doi: 10.1007/s00784-016-1980-3 URL
[10]	Mukherjee PK, Chandra J, Retuerto M , et al. Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi[J]. PLoS Pathog, 2014,10(3):e1003996. doi: 10.1371/journal.ppat.1003996 URL
[11]	Ricker A, Vickerman M, Dongari-Bagtzoglou A . Streptococcus gordonii glucosyltransferase promotes biofilm interactions with Candida albicans[J]. J Oral Microbiol, 2014,6(1):23419. doi: 10.3402/jom.v6.23419 URL
[12]	Falsetta ML, Klein MI, Colonne PM , et al. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo[J]. Infect Immun, 2014,82(5):1968-1981. doi: 10.1128/IAI.00087-14 URL
[13]	Harriott MM, Noverr MC . Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance[J]. Antimicrob Agents Chemother, 2009,53(9):3914-3922. doi: 10.1128/AAC.00657-09 URL
[14]	Hogan DA, Vik Å, Kolter R . A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology[J]. Mol Microbiol, 2004,54(5):1212-1223. doi: 10.1111/j.1365-2958.2004.04349.x URL
[15]	Jarosz LM, Deng DM, van der Mei HC , et al. Streptococcus mutans competence-stimulating peptide inhibits Candida albicans hypha formation[J]. Eukaryotic Cell, 2009,8(11):1658-1664. doi: 10.1128/EC.00070-09 URL pmid: 19717744
[16]	Marsland BJ, Gollwitzer ES . Host-microorganism interactions in lung diseases[J]. Nat Rev Immunol, 2014,14(12):827-835.
[17]	Tipton L, Ghedin E, Morris A . The lung mycobiome in the next-generation sequencing era[J]. Virulence, 2017,8(3):334-341. doi: 10.1080/21505594.2016.1235671 URL
[18]	Kim SH, Clark ST, Surendra A , et al. Global analysis of the fungal microbiome in cystic fibrosis patients reveals loss of function of the transcriptional repressor Nrg1 as a mechanism of pathogen adaptation[J]. PLoS Pathog, 2015,11(11):e1005308. doi: 10.1371/journal.ppat.1005308 URL
[19]	Charlson ES, Diamond JM, Bittinger K , et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant[J]. Am J Respir Crit Care Med, 2012,186(6):536-545. doi: 10.1164/rccm.201204-0693OC URL
[20]	von Rosenvinge EC, Song Y, White JR , et al. Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota[J]. ISME J, 2013,7(7):1354-1366.
[21]	Ott SJ, Kühbacher T, Musfeldt M , et al. Fungi and inflammatory bowel diseases: alterations of composition and diversity[J]. Scand J Gastroenterol, 2008,43(7):831-841. doi: 10.1080/00365520801935434 URL
[22]	Hamad I, Sokhna C, Raoult D , et al. Molecular detection of eukaryotes in a single human stool sample from senegal[J]. PLoS One, 2012,7(7):e40888. doi: 10.1371/journal.pone.0040888 URL
[23]	Hoffmann C, Dollive S, Grunberg S , et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents[J]. PLoS One, 2013,8(6):e66019. doi: 10.1371/journal.pone.0066019 URL
[24]	Mar Rodríguez M, Pérez D, Javier Chaves F , et al. Erratum: obesity changes the human gut mycobiome[J]. Sci Rep, 2016,6:21679.
[25]	Suhr MJ, Hallen-Adams HE . The human gut mycobiome: pitfalls and potentials—a mycologist’s perspective[J]. Mycologia, 2015,107(6):1057-1073. doi: 10.3852/15-147 URL
[26]	Luan CG, Xie LL, Yang X , et al. Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas[J]. Sci Rep, 2015,5:7980.
[27]	Sokol H, Leducq V, Aschard H , et al. Fungal microbiotadysbiosis in IBD[J]. Gut, 2017,66(6):1039-1048. doi: 10.1136/gutjnl-2015-310746 URL
[28]	Dollive S, Chen YY, Grunberg S , et al. Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment[J]. PLoS One, 2013,8(8):e71806. doi: 10.1371/journal.pone.0071806 URL
[29]	Erb Downward JR, Falkowski NR, Mason KL , et al. Modulation of post-antibiotic bacterial community reassembly and host response by candida albicans[J]. Sci Rep, 2013,3:2191. doi: 10.1038/srep02191 pmid: 3709164
[30]	Seed PC . The human mycobiome[J]. Cold Spring HarbPerspect Med, 2014,5(5):a019810.
[31]	Cui LJ, Morris A, Ghedin E . The human mycobiome in health and disease[J]. Genome Med, 2013,5(7):63. doi: 10.1186/gm467 URL
[32]	Rizzetto L, de Filippo C, Cavalieri D . Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease[J]. Eur J Immunol, 2014,44(11):3166-3181. doi: 10.1002/eji.201344403 URL pmid: 25257052
[33]	Guo RY, Zheng NN, Lu HF , et al. Increased diversity of fungal flora in the vagina of patients with recurrent vaginal candidiasis and allergic rhinitis[J]. Microbial Ecology, 2012,64(4):918-927. doi: 10.1007/s00248-012-0084-0 URL
[34]	Farr A, Kiss H, Holzer I , et al. Effect of asymptomatic vaginal colonization with Candida albicans on pregnancy outcome[J]. Acta Obstet Gynecol Scand, 2015,94(9):989-996. doi: 10.1111/aogs.2015.94.issue-9 URL
[35]	Köhler GA, Assefa S, Reid G . Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans[J]. Infect Dis Obstet Gynecol, 2012,2012:636474.
[36]	Findley K, Oh J, Yang J , et al. Topographic diversity of fungal and bacterial communities in human skin[J]. Nature, 2013,498(7454):367-370.
[37]	Oh J, Byrd AL, Park M , et al. Temporal stability of the human skin microbiome[J]. Cell, 2016,165(4):854-866. doi: 10.1016/j.cell.2016.04.008 URL
[38]	Schommer NN, Gallo RL . Structure and function of the human skin microbiome[J]. Trends Microbiol, 2013,21(12):660-668. doi: 10.1016/j.tim.2013.10.001 URL
[39]	Kalan L, Loesche M, Hodkinson BP , et al. Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, associated with delayed healing[J]. MBio, 2016, 7(5). pii:e01058-16.
[40]	Taylor PR, Tsoni SV, Willment JA , et al. Dectin-1 is required for β-glucan recognition and control of fungal infection[J]. Nat Immunol, 2007,8(1):31-38. doi: 10.1038/ni1408 URL pmid: 1888731
[41]	Hise AG, Tomalka J, Ganesan S , et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans[J]. Cell Host Microbe, 2009,5(5):487-497. doi: 10.1016/j.chom.2009.05.002 URL
[42]	Gessner MA, Werner JL, Lilly LM , et al. Dectin-1-dependent interleukin-22 contributes to early innate lung defense against aspergillus fumigatus[J]. Infect Immun, 2012,80(1):410-417. doi: 10.1128/IAI.05939-11 URL
[43]	Kashem SW, Igyártó BZ, Gerami-Nejad M , et al. Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation[J]. Immunity, 2015,42(2):356-366. doi: 10.1016/j.immuni.2015.01.008 URL
[44]	Underhill DM, Iliev ID . The mycobiota: interactions between commensal fungi and the host immune system[J]. Nat Rev Immunol, 2014,14(6):405-416.